We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ENCOURAGES RiskMAPS TO MITIGATE PRODUCT RISK
FDA ENCOURAGES RiskMAPS TO MITIGATE PRODUCT RISK
May 19, 2004
Drugmakers that implement detailed, proactive risk management action plans (RiskMAPs) can minimize the impact of known risks associated with approved drugs without encumbering product availability, according to a draft guidance released earlier this month by the agency.